(Q54481754)

30 May 2018

title

When to order a biopsy to characterise a metastatic relapse in breast cancer. (English)

1 reference

30 May 2018

0 references

1

1 reference

30 May 2018

author name string

G Åström

2

1 reference

30 May 2018

L Lindström

3

1 reference

30 May 2018

T Hatschek

4

1 reference

30 May 2018

J Bergh

5

1 reference

30 May 2018

publication date

1 September 2012

1 reference

30 May 2018

published in

Annals of Oncology

1 reference

30 May 2018

volume

23 Suppl 10

1 reference

30 May 2018

page(s)

x349-53

1 reference

30 May 2018

The variability of estrogen receptors in metastatic breast cancer

cites work

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDS297

Variation in receptor status between primary and metastatic breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDS297

Oestrogen receptor status of primary breast carcinomas and their metastases. Relation to pattern of spread and survival after recurrence

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDS297

Prognostic impact of discordance between triple-receptor measurements in primary and recurrent breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDS297

Triple-Negative Breast Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDS297

Human epidermal growth factor receptor 2-positive breast cancer and central nervous system metastases

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDS297

Third consensus on medical treatment of metastatic breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDS297

Quantitative imaging of estrogen receptor expression in breast cancer with PET and 18F-fluoroestradiol

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDS297

Should liver metastases of breast cancer be biopsied to improve treatment choice?

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDS297

Comparison of HER-2 and hormone receptor expression in primary breast cancers and asynchronous paired metastases: impact on patient management

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDS297

Clinically used breast cancer markers such as estrogen receptor, progesterone receptor, and human epidermal growth factor receptor 2 are unstable throughout tumor progression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDS297

Impact of metastatic estrogen receptor and progesterone receptor status on survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDS297

Does confirmatory tumor biopsy alter the management of breast cancer patients with distant metastases?

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDS297

Heterogeneity of breast cancer metastases: comparison of therapeutic target expression and promoter methylation between primary tumors and their multifocal metastases

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDS297

Serum HER-2/neu conversion to positive at the time of disease progression in patients with breast carcinoma on hormone therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDS297

HER-2/neu expression in primary and metastatic breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDS297

HER-2 gene amplification can be acquired as breast cancer progresses

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDS297

Stability of HER-2/neu expression over time and at multiple metastatic sites

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDS297

HER2 gene status in primary breast cancers and matched distant metastases

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDS297

Comparison of HER-2 overexpression in primary breast cancer and metastatic sites and its effect on biological targeting therapy of metastatic disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDS297

Loss of human epidermal growth factor receptor 2 (HER2) expression in metastatic sites of HER2-overexpressing primary breast tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDS297

Prospective study evaluating the impact of tissue confirmation of metastatic disease in patients with breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDS297

Prospective comparison of switches in biomarker status between primary and recurrent breast cancer: the Breast Recurrence In Tissues Study (BRITS).

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDS297

Tissue confirmation of disease recurrence in breast cancer patients: pooled analysis of multi-centre, multi-disciplinary prospective studies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDS297

American Society of Clinical Oncology/College Of American Pathologists guideline recommendations for immunohistochemical testing of estrogen and progesterone receptors in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDS297

American Society of Clinical Oncology/College of American Pathologists guideline recommendations for human epidermal growth factor receptor 2 testing in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDS297

Genome remodelling in a basal-like breast cancer metastasis and xenograft

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDS297

A diagnostic paradigm for resectable liver lesions: to biopsy or not to biopsy?

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDS297

Biopsy of liver metastasis for women with breast cancer: Impact on survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDS297

21 January 2018

Identifiers

DOI

10.1093/ANNONC/MDS297

1 reference

30 May 2018

PubMed ID

22987990

1 reference

30 May 2018